While existing vascular stents, made of metal, come in different sizes to accommodate a variety of patients, a new technology offers complete personalization according to an individual’s precise ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9r4nlm/medipoint) has announced the addition of the "MediPoint: Peripheral ...

A stent while you’re stable may prevent urgent care. For some people with stable coronary artery disease (CAD), having a stent or stents put in now along with standard medical therapy significantly ...

Vascular stent implantation is feasible and likely to provide clinical benefit in select patients who have central vascular obstruction due to fibrosing mediastinitis (FM), according to the first ...

Rise in adoption of minimally invasive surgical procedures and presence of key players that drive the growth of the global non vascular stent market. However, regulatory compliance is anticipated to ...

W.L. Gore and Associates announced that the FDA has approved the Tigris Vascular Stent for the treatment of patients with peripheral artery disease, according to a company press release. The ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the U.S. Food and Drug Administration (FDA) approval of the GORE® TIGRIS® Vascular Stent, a dual-component stent ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHILADELPHIA -- ...

The Guthrie Clinic proudly announces a significant advancement in regional vascular care with the successful completion of ...

Patients have been treated with a new technology for vascular disease for the first time in the UK, the NHS has said.

FLAGSTAFF, Ariz., W. L. Gore & Associates, Inc. (Gore) today announced the U.S. Food and Drug Administration (FDA) approval of the GORE® TIGRIS® Vascular Stent, a dual-component stent with a unique ...